LipidFlex™ Premade Lipid Nanoparticle T Cell Screening Set

The LipidFlex™ T Cell Premade LNP Screening Set delivers 10 pre-formulated mRNA lipid nanoparticles, each featuring a different ionizable cationic lipid optimized for T cell transfection applications. This ready-to-use screening platform eliminates the time-consuming formulation process, allowing researchers to quickly identify the most effective LNP composition for their specific T cell delivery needs.

Key Features

Pre-optimized formulations: Each LNP contains ionizable lipid, DSPC, cholesterol, and DMG-PEG2000 at carefully balanced molar ratios
High encapsulation efficiency: Formulated to maximize mRNA loading and delivery performance
Validated lipid selection: Features the most widely cited ionizable lipids from peer-reviewed T cell transfection studies
Research-ready concentration: Supplied at 0.1 mg/ml in TBS buffer for immediate use

Applications

Ideal for researchers developing:

T cell engineering protocols
CAR-T cell therapies
Immunotherapy applications
mRNA delivery optimization studies

Technology Advantage

Our lipid nanoparticle technology provides simple and efficient mRNA delivery to activated T cells, enabling reproducible transfection results across diverse research applications. Each formulation in the screening set has been pre-validated for optimal nucleic acid cargo delivery, saving valuable laboratory time and resources.

For laboratories seeking to accelerate their T cell research timeline while maintaining the highest standards of delivery efficiency.

Payload:	Firefly Luciferase mRNA
Ionizable lipid:	SM-102, DLin-MC3-DMA, C12-200, cKK-E12, Lipid A9, C14-4, C14-O2, E10i-494, Lipid C2, 9322-O16B
Formulation:	Ionizable lipid, DSPC, PEG-2000 DMG, Cholesetrol
Storage Buffer:	10% Sucrose in TBS
Storage:	-20° C or below. We recommend to minimize freeze-thaw cycles to preserve LNPs integrity.
Shipping:	Dry ice
Handling:	Avoid freeze and thaw
Concentration:	~0.1 mg/mL
Stock:	On-demand